CLINICAL APPLICATION & CRITERIA
Proton Therapy in China
Proton therapy is an advanced form of radiation that uses accelerated hydrogen protons instead of X-rays, exploiting the Bragg peak to concentrate radiation dose within the tumor while delivering almost no exit dose to surrounding healthy tissue. Pencil beam scanning enables intensity-modulated proton therapy (IMPT), painting dose layer by layer for highly conformal treatment. With a substantially lower integral radiation dose than photon therapy, protons may reduce integral dose and, in selected patients, may reduce long-term toxicity — making them especially valuable for pediatric patients and tumors adjacent to critical structures such as the brain, heart, and eyes.
- No Exit Dose Beyond the Bragg Peak
- Pencil Beam Scanning
- Pediatric Dose-Sparing Advantage
- Selected Re-Irradiation Applications
- Critical Organ Sparing
- Advanced Image Guidance
CLINICAL CANCER INDICATIONS
Key Cancers Treated with Proton Therapy in China
Millimeter-accurate Bragg peak radiation eliminating exit dose to critical organs and healthy surrounding tissues across national particle centers:
WHY CHOOSE US
Why Choose China Cancer Help for Proton Therapy
A specialized cross-border continuum connecting international patients directly with China’s leading proton therapy centers.
China now operates more than 30 proton centers or facilities under construction — accounting for over half of all new global projects. Benefiting from a powerful late-mover advantage, nearly every newly built Chinese center directly adopts the latest pencil beam scanning and image-guided technology, skipping older passive-scattering generations. Domestic breakthroughs in compact superconducting cyclotrons, rotating gantries, and treatment planning systems by United Imaging, China General Nuclear, and the Hefei Institutes of Physical Science have broken foreign monopolies and reduced equipment costs.
Treatment in China costs approximately ¥250,000–350,000 (US5,000–49,000), a fraction of US and European pricing. Chinese centers contribute world-leading clinical data on high-incidence tumor types including nasopharyngeal carcinoma, glioma, and esophageal cancer. With bilingual medical coordinators, JCI-equivalent quality systems, and international patient services at leading centers in Shanghai, Beijing, Guangzhou, and beyond, China has become a trusted proton therapy destination for patients across Asia and beyond.
CASE EVALUATION PATHWAY
A Structured Pathway from Records to Care
A transparent, four-stage continuum connecting preliminary clinical evaluation to official hospital acceptance, specialized inpatient care, and ongoing continuity.
01. Submit Records Online
02. Pre-Screen & Doctor Match
03. Doctor Consultation
04. Travel to China & Care
PATIENT FAQS
Frequently Asked Questions
Key clinical, financial, and logistical insights for international Proton Beam Therapy patients considering care in China.
PROTON THERAPY PRE-ASSESSMENT
Request a Confidential Case Review for Proton Therapy
Submit your contact details, confirmed diagnosis, and main question below. You do not need to upload any medical files at this stage. Our clinical coordinator will contact you directly within 24–48 hours to discuss potential proton beam therapy pathways in China and assist you in gathering the specific medical records needed for expert hospital review.